{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:44:28Z","timestamp":1792597468203,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1093-4","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:14:27Z","timestamp":1557299667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6963-1503","authenticated-orcid":false,"given":"Selvihan","family":"Beysel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Kizilgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Apaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyfullah","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erman","family":"Cakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab. 2014;99:3580\u201394.","journal-title":"J Clin Endocrinol Metab"},{"key":"1093_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.14310\/horm.2002.1370","volume":"11","author":"G D\u00edaz-Soto","year":"2012","unstructured":"D\u00edaz-Soto G, Juli\u00e1n MT, Puig-Domingo M. Normocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic intervention. Hormones (Athens). 2012;11:390\u20136.","journal-title":"Hormones (Athens)"},{"key":"1093_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","volume":"54","author":"JP Bilezikian","year":"2010","unstructured":"Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metabol. 2010;54:106\u20139.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1093_CR4","doi-asserted-by":"publisher","first-page":"128352","DOI":"10.1155\/2012\/128352","volume":"2012","author":"LM Amaral","year":"2012","unstructured":"Amaral LM, Queiroz DC, Marques TF, Mendes M, Bandeira F. Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone? J Osteoporos. 2012;2012:128352.","journal-title":"J Osteoporos"},{"key":"1093_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","volume":"16","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom Off J Int Soc Clin Densitom. 2013;16:33\u20139.","journal-title":"J Clin Densitom Off J Int Soc Clin Densitom"},{"key":"1093_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF03345719","volume":"32","author":"R Luboshitzky","year":"2009","unstructured":"Luboshitzky R, Chertok-Schaham Y, Lavi I, Ishay A. Cardiovascular risk factors in primary hyperparathyroidism. J Endocrinol Investig. 2009;32:317\u201321.","journal-title":"J Endocrinol Investig"},{"key":"1093_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s12020-013-0059-z","volume":"44","author":"F Tassone","year":"2013","unstructured":"Tassone F, Maccario M, Gianotti L, Baffoni C, Pellegrino M, et al. Insulin sensitivity in normocalcaemic primary hyperparathyroidism. Endocrine. 2013;44:812\u20134.","journal-title":"Endocrine"},{"key":"1093_CR8","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1210\/jc.2011-0238","volume":"96","author":"P Farahnak","year":"2011","unstructured":"Farahnak P, L\u00e4rfars G, Sten-Linder M, Nilsson I-L. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. J Clin Endocrinol Metab. 2011;96:2112\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1093_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.0300-0664.2001.01468.x","volume":"56","author":"E Hagstr\u00f6m","year":"2002","unstructured":"Hagstr\u00f6m E, Lundgren E, Lithell H, Berglund L, Ljunghall S, et al. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol. 2002;56:253\u201360.","journal-title":"Clin Endocrinol"},{"key":"1093_CR10","first-page":"584","volume":"17","author":"A Ishay","year":"2011","unstructured":"Ishay A, Herer P, Luboshitzky R. Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2011;17:584\u201390.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"1093_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12020-013-0091-z","volume":"47","author":"M Procopio","year":"2014","unstructured":"Procopio M, Barale M, Bertaina S, Sigrist S, Mazzetti, et al. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine. 2014;47:581\u20139.","journal-title":"Endocrine"},{"key":"1093_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2265.2009.03558.x","volume":"71","author":"T Ahlstr\u00f6m","year":"2009","unstructured":"Ahlstr\u00f6m T, Hagstr\u00f6m E, Larsson A, Rudberg C, Lind L, et al. Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol. 2009;71:673\u20138.","journal-title":"Clin Endocrinol"},{"key":"1093_CR13","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1161\/ATVBAHA.113.303062","volume":"34","author":"E Hagstr\u00f6m","year":"2014","unstructured":"Hagstr\u00f6m E, Micha\u00eblsson K, Melhus H, Hansen T, Ahlstr\u00f6m H, et al. Plasma-parathyroid hormone is associated with subclinical and clinical atherosclerotic disease in 2 community-based cohorts. Arterioscler Thromb Vasc Biol. 2014;34:1567\u201373.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1093_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1530\/eje.0.1410350","volume":"141","author":"R Jorde","year":"1999","unstructured":"Jorde R, Bonaa KH, Sundsfjord J. Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Troms\u00f8 study. Eur J Endocrinol Eur Fed Endocr Soc. 1999;141:350\u20137.","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"1093_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/joim.12464","volume":"279","author":"IR Reid","year":"2016","unstructured":"Reid IR, Gamble GD, Bolland MJ. Circulating calcium concentrations, vascular disease and mortality: a systematic review. J Intern Med. 2016;279:524\u201340.","journal-title":"J Intern Med."},{"key":"1093_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1530\/EJE-09-1067","volume":"162","author":"KM Tordjman","year":"2010","unstructured":"Tordjman KM, Yaron M, Izkhakov E, Osher E, Shenkerman G, et al. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol Eur Fed Endocr Soc. 2010;162:925\u201333.","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"1093_CR17","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1210\/jcem.86.11.7880","volume":"86","author":"KJ Mather","year":"2001","unstructured":"Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab. 2001;86:5457\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"1093_CR18","unstructured":"Framingham, Heart study from: \n                    https:\/\/reference.medscape.com\/calculator\/framingham-cardiovascular-disease-risk\n                    \n                   [viewed September 2014]."},{"key":"1093_CR19","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1210\/jc.2004-1891","volume":"90","author":"MJ Bolland","year":"2005","unstructured":"Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab. 2005;90:1525\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"1093_CR20","first-page":"69","volume":"11","author":"E Kamycheva","year":"2004","unstructured":"Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Troms\u00f8 study. Eur J Cardiovasc Prev Rehabil Off J Eur Soc Cardiol Work Groups Epidemiol Prev Card Rehabil Exerc Physiol. 2004;11:69\u201374.","journal-title":"Eur J Cardiovasc Prev Rehabil Off J Eur Soc Cardiol Work Groups Epidemiol Prev Card Rehabil Exerc Physiol"},{"key":"1093_CR21","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2337\/dc06-2438","volume":"30","author":"JP Reis","year":"2007","unstructured":"Reis JP, von M\u00fchlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30:1549\u201355.","journal-title":"Diabetes Care"},{"key":"1093_CR22","first-page":"548","volume":"35","author":"D Han","year":"2012","unstructured":"Han D, Trooskin S, Wang X. Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J Endocrinol Investig. 2012;35:548\u201352.","journal-title":"J Endocrinol Investig"},{"key":"1093_CR23","first-page":"841","volume":"35","author":"F Tassone","year":"2012","unstructured":"Tassone F, Gianotti L, Baffoni C, Cesario F, Magro G, et al. Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism. J Endocrinol Investig. 2012;35:841\u20136.","journal-title":"J Endocrinol Investig"},{"key":"1093_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/dmrr.637","volume":"23","author":"AA Khaleeli","year":"2007","unstructured":"Khaleeli AA, Johnson JN, Taylor WH. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes Metab Res Rev. 2007;23:43\u20138.","journal-title":"Diabetes Metab Res Rev"},{"key":"1093_CR25","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.surg.2005.02.001","volume":"137","author":"I-L Nilsson","year":"2005","unstructured":"Nilsson I-L, Aberg J, Rastad J, Lind L. Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery. 2005;137:632\u20138.","journal-title":"Surgery"},{"key":"1093_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1507\/endocrj.EJ15-0392","volume":"63","author":"F Yener Ozturk","year":"2016","unstructured":"Yener Ozturk F, Erol S, Canat MM, Karatas S, Kuzu I, et al. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients. Endocr J. 2016;63:111\u20138.","journal-title":"Endocr J."},{"key":"1093_CR27","first-page":"23","volume":"21","author":"S Temizkan","year":"2015","unstructured":"Temizkan S, Kocak O, Aydin K, Ozderya A, Arslan G, et al. Normocalcemic hyperparathyroidism and insulin resistance. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2015;21:23\u20139.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"1093_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/eje.1.02173","volume":"155","author":"E Hagstr\u00f6m","year":"2006","unstructured":"Hagstr\u00f6m E, Lundgren E, Rastad J, Hellman P. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur J Endocrinol Eur Fed Endocr Soc. 2006;155:33\u20139.","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"1093_CR29","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1210\/jc.2014-4432","volume":"100","author":"G Chen","year":"2015","unstructured":"Chen G, Xue Y, Zhang Q, Xue T, Yao J, et al. Is Normocalcemic primary hyperparathyroidism harmful or harmless? J Clin Endocrinol Metab. 2015;100:2420\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"655\u2013664","key":"1093_CR30","first-page":"664.e1","volume":"165","author":"AJ Van Ballegooijen","year":"2013","unstructured":"Van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA. Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies. Am Heart J. 2013;165(655\u2013664):664.e1\u20135.","journal-title":"Am Heart J"},{"key":"1093_CR31","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","volume":"119","author":"E Hagstr\u00f6m","year":"2009","unstructured":"Hagstr\u00f6m E, Hellman P, Larsson TE, Ingelsson E, Berglund L, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009;119:2765\u201371.","journal-title":"Circulation"},{"key":"1093_CR32","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/01.hjh.0000179764.40701.36","volume":"23","author":"R Jorde","year":"2005","unstructured":"Jorde R, Svartberg J, Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. J Hypertens. 2005;23:1639\u201344.","journal-title":"J Hypertens"},{"key":"1093_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1530\/EJE-09-0496","volume":"161","author":"DM Lee","year":"2009","unstructured":"Lee DM, Rutter MK, O\u2019Neill TW, Boonen S, Vanderschueren D, et al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol Eur Fed Endocr Soc. 2009;161:947\u201354.","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"1093_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2796.2007.01778.x","volume":"261","author":"MB Snijder","year":"2007","unstructured":"Snijder MB, Lips P, Seidell JC, Visser M, Deeg DJH, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007;261:558\u201365.","journal-title":"J Intern Med"},{"key":"1093_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2840-8-7","volume":"8","author":"J Hjelmesaeth","year":"2009","unstructured":"Hjelmesaeth J, Hofs\u00f8 D, Aasheim ET, Jenssen T, Moan J, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol. 2009;8:7.","journal-title":"Cardiovasc Diabetol"},{"key":"1093_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","volume":"63","author":"A Tomaschitz","year":"2014","unstructured":"Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, et al. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism. 2014;63:20\u201331.","journal-title":"Metabolism"},{"key":"1093_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.regpep.2011.06.002","volume":"171","author":"SA Potthoff","year":"2011","unstructured":"Potthoff SA, Janus A, Hoch H, Frahnert M, Tossios P, et al. PTH-receptors regulate norepinephrine release in human heart and kidney. Regul Pept. 2011;171:35\u201342.","journal-title":"Regul Pept"},{"key":"1093_CR38","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.111.081307","volume":"126","author":"E Osto","year":"2012","unstructured":"Osto E, Fallo F, Pelizzo MR, Maddalozzo A, Sorgato N, et al. Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation. 2012;126:1031\u20139.","journal-title":"Circulation"},{"key":"1093_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/00365513.2010.543694","volume":"71","author":"EG Almqvist","year":"2011","unstructured":"Almqvist EG, Bondeson A-G, Bondeson L, Svensson J. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism. Scand J Clin Lab Invest. 2011;71:139\u201344.","journal-title":"Scand J Clin Lab Invest"},{"key":"1093_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1210\/jc.2011-2107","volume":"97","author":"S Iwata","year":"2012","unstructured":"Iwata S, Walker MD, Di Tullio MR, Hyodo E, Jin Z, et al. Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2012;97:132\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"1093_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","volume":"56","author":"E Delfini","year":"2007","unstructured":"Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, et al. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism. 2007;56:30\u20136.","journal-title":"Metabolism"},{"key":"1093_CR42","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1210\/jc.2010-2781","volume":"96","author":"D Sukumar","year":"2011","unstructured":"Sukumar D, Partridge NC, Wang X, Shapses SA. The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity. J Clin Endocrinol Metab. 2011;96:1852\u20138.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1093-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1093-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1093-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T19:15:45Z","timestamp":1588792545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1093-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1093-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"12 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by Diskapi Yildirim Beyazit Teaching and Research Hospital Ethics Board (No: 12.4.2015\u201325\/04) and in written informed consent was obtained from the patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"106"}}